Literature DB >> 19061706

Twenty-two years of follow-up results of balloon angioplasty for discreet native coarctation of the aorta in adolescents and adults.

Mohamed Eid Fawzy1, Ahmed Fathala, Adil Osman, Amr Badr, Mohammed Adel Mostafa, Gamal Mohamed, Bruce Dunn.   

Abstract

BACKGROUND AND AIMS: Although the immediate and intermediate-term results of balloon angioplasty (BA) for patients with aortic coarctation (AC) have been encouraging, there is paucity of data on long-term follow-up results. This study evaluated the long-term (up to 22 years) follow-up results of BA in adolescent and adult patients with discrete (shelf-like) coarctation of the aorta.
METHODS: Follow-up data of 58 patients (mean age 24+/-9 years) undergoing BA for discrete AC at median interval of 13.4 years including cardiac catheterization, magnetic resonance imaging, and Doppler echocardiography form the basis of this study.
RESULTS: No early deaths occurred. Balloon angioplasty produced immediate reduction in peak AC gradient from 60+/-22 mm Hg to 8.5+/-8 mm Hg (P<.0001). Follow-up catheterization 12 months later revealed a residual gradient of 5+/-6.4 mm Hg (P=.01). Five patients (8%) with suboptimal initial outcome (peak gradient>20 mm Hg) developed restenosis, and 4 of these had successful repeat angioplasty. Aneurysm developed at the site of dilatation in 4 patients (7%). Magnetic resonance imaging follow-up results revealed no new aneurysm. In one patient, the aneurysm increased in size, but no recoarctation or appreciable changes in the Doppler gradient across the AC site was noted. The blood pressure had normalized without medical treatment in 29 (50%) of the 58 patients.
CONCLUSION: Long-term results of BA for discrete AC are excellent and should be considered as first option for treatment of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 19061706     DOI: 10.1016/j.ahj.2008.06.037

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Coarctation of the aorta: management, indications for intervention, and advances in care.

Authors:  Mohammed Haris Umer Usman; Pablo Rengifo-Moreno; Sean F Janzer; Ignacio Inglessis-Azuaje; Christian Witzke-Sanz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

Review 2.  The Challenges of Redo Aortic Coarctation Repair in Adults.

Authors:  Jonathan D Price; Damien J LaPar
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

3.  Congenital Heart Defects in Adults : A Field Guide for Cardiologists.

Authors:  Anitra Romfh; Francesca Romana Pluchinotta; Prashob Porayette; Anne Marie Valente; Stephen P Sanders
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

Review 4.  Treatment of Hypertension in Coarctation of the Aorta.

Authors:  Kenta Nakamura; Ada Stefanescu Schmidt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-06

Review 5.  Coarctation of the aorta: Management from infancy to adulthood.

Authors:  Rachel D Torok; Michael J Campbell; Gregory A Fleming; Kevin D Hill
Journal:  World J Cardiol       Date:  2015-11-26

6.  Surgical Management of Aortic Coarctation from Infant to Adult.

Authors:  Ugur Kaya; Abdurrahim Colak; Necip Becit; Munacettin Ceviz; Hikmet Kocak
Journal:  Eurasian J Med       Date:  2017-12-29

7.  A novel approach to the balloon angioplasty of a native discrete severe coarctation of the aorta in the management of hypertension.

Authors:  Mahmoud Ebrahimi
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

8.  Our first experience in stenting of coarctation of aorta in infants and small children; A case series study.

Authors:  Mehdi Ghaderian; Mohammad Reza Sabri; Alireza Ahmadi; Sargol Bayat
Journal:  ARYA Atheroscler       Date:  2019-03

Review 9.  Current management of coarctation of the aorta.

Authors:  Hussam Suradi; Ziyad M Hijazi
Journal:  Glob Cardiol Sci Pract       Date:  2015-11-18

Review 10.  What Interventional Cardiologists Are Still Leaving to the Surgeons?

Authors:  Worakan Promphan; Shakeel A Qureshi
Journal:  Front Pediatr       Date:  2016-06-13       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.